Atricure logo

Atricure share price today

(ATRC)

Atricure share price is $33.47 & ₹2,872.06 as on 7 Jan 2025, 2.30 'hrs' IST

$33.47

1.44

(4.5%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Atricure share price in Dollar and Rupees. Guide to invest in Atricure stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Atricure, along with analyst recommendations, forecasts, and comprehensive financials.

Atricure share price movements

  • Today's Low: $32.49
    Today's High: $34.25

    Day's Volatility :5.14%

  • 52 Weeks Low: $18.94
    52 Weeks High: $39.05

    52 Weeks Volatility :51.49%

Atricure Returns

PeriodAtricure IncSector (Health Care)Index (Russel 2000)
3 Months
17.24%
-8.4%
0.0%
6 Months
44.02%
-3.8%
0.0%
1 Year
-8.56%
-0.1%
0.0%
3 Years
-51.75%
2.9%
-19.8%

Atricure Key Statistics

in dollars & INR

Previous Close
$32.03
Open
$32.12
Today's High
$34.25
Today's Low
$32.49
Market Capitalization
$1.6B
Today's Volume
$432.7K
52 Week High
$39.045
52 Week Low
$18.94
Revenue TTM
$447.6M
EBITDA
$-16.1M
Earnings Per Share (EPS)
$-0.87
Profit Margin
-8.7%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-8.39%

How to invest in Atricure from India?

It is very easy for Indian residents to invest directly in Atricure from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Atricure stock in both Indian Rupees (INR) and US Dollars (USD). Search for Atricure or ATRC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Atricure or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Atricure shares which would translate to 0.026 fractional shares of Atricure as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Atricure, in just a few clicks!

Returns in Atricure for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Atricure investment value today

Current value as on today

₹98,769

Returns

₹1,231

(-1.23%)

Returns from Atricure Stock

₹4,453 (-4.45%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Atricure

-25%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Atricure on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -25% less investors are searching Atricure in the last 30 days versus the previous period.

Global Institutional Holdings in Atricure

  • Vanguard Group Inc

    9.56%

  • BlackRock Inc

    9.47%

  • AllianceBernstein L.P.

    8.15%

  • Hood River Capital Management LLC

    5.81%

  • Champlain Investment Partners, LLC

    5.72%

  • Macquarie Group Ltd

    4.89%

Analyst Recommendation on Atricure

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Atricure(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
13
13
Hold
1
2
2
Sell
0
0
0

Analyst Forecast on Atricure

What analysts predicted

Upside of 34.78%

Current:

$33.47

Target:

$45.11

Insights on Atricure

  • Price Movement

    In the last 7 days, ATRC stock has moved up by 5.9%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 116.26M → 115.91M (in $), with an average decrease of 0.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -13.26M → -7.85M (in $), with an average increase of 33.8% per quarter
  • ATRC vs ISRG (1 yr)

    In the last 1 year, Intuitive Surgical, Inc. has given 66.0% return, outperforming this stock by 69.0%
  • ATRC vs ISRG (3 yr)

    In the last 3 years, Intuitive Surgical, Inc. has given 60.2% return, outperforming this stock by 110.9%
  • Price to Sales

    ForATRC every $1 of sales, investors are willing to pay $3.3, whereas for Intuitive Surgical, Inc., the investors are paying $24.1 for every $1 of sales.

Atricure Financials in INR & Dollars

FY18Y/Y Change
Revenue
$201.6M
↑ 15.4%
Net Income
$-21.1M
↓ 21.4%
Net Profit Margin
-10.48%
↑ 4.91%
FY19Y/Y Change
Revenue
$230.8M
↑ 14.47%
Net Income
$-35.2M
↑ 66.5%
Net Profit Margin
-15.25%
↓ 4.77%
FY20Y/Y Change
Revenue
$206.5M
↓ 10.52%
Net Income
$-48.2M
↑ 36.83%
Net Profit Margin
-23.32%
↓ 8.07%
FY21Y/Y Change
Revenue
$274.3M
↑ 32.83%
Net Income
$50.2M
↓ 204.24%
Net Profit Margin
18.3%
↑ 41.62%
FY22Y/Y Change
Revenue
$330.4M
↑ 20.43%
Net Income
$-46.5M
↓ 192.56%
Net Profit Margin
-14.06%
↓ 32.36%
FY23Y/Y Change
Revenue
$399.2M
↑ 20.84%
Net Income
$-30.4M
↓ 34.49%
Net Profit Margin
-7.62%
↑ 6.44%
Q2 FY23Q/Q Change
Revenue
$100.9M
↑ 7.94%
Net Income
$-5.1M
↓ 20.97%
Net Profit Margin
-5.07%
↑ 1.86%
Q3 FY23Q/Q Change
Revenue
$98.3M
↓ 2.6%
Net Income
$-9.1M
↑ 76.92%
Net Profit Margin
-9.21%
↓ 4.14%
Q4 FY23Q/Q Change
Revenue
$106.5M
↑ 8.4%
Net Income
$-9.8M
↑ 8.11%
Net Profit Margin
-9.19%
↑ 0.02%
Q1 FY24Q/Q Change
Revenue
$108.9M
↑ 2.17%
Net Income
$-13.3M
↑ 35.55%
Net Profit Margin
-12.19%
↓ 3.0%
Q2 FY24Q/Q Change
Revenue
$116.3M
↑ 6.81%
Net Income
$-8.0M
↓ 39.65%
Net Profit Margin
-6.89%
↑ 5.3%
Q3 FY24Q/Q Change
Revenue
$115.9M
↓ 0.31%
Net Income
$-7.9M
↓ 1.94%
Net Profit Margin
-6.78%
↑ 0.11%
FY18Y/Y Change
Profit
$147.1M
↑ 16.61%
FY19Y/Y Change
Profit
$170.3M
↑ 15.78%
FY20Y/Y Change
Profit
$149.3M
↓ 12.34%
FY21Y/Y Change
Profit
$205.9M
↑ 37.88%
FY22Y/Y Change
Profit
$245.9M
↑ 19.47%
FY23Y/Y Change
Profit
$300.4M
↑ 22.13%
Q2 FY23Q/Q Change
Profit
$77.1M
↑ 10.73%
Q3 FY23Q/Q Change
Profit
$73.9M
↓ 4.16%
Q4 FY23Q/Q Change
Profit
$79.1M
↑ 7.05%
Q1 FY24Q/Q Change
Profit
$80.5M
↑ 1.84%
Q2 FY24Q/Q Change
Profit
$86.1M
↑ 6.9%
Q3 FY24Q/Q Change
Profit
$86.8M
↑ 0.82%
FY18Y/Y Change
Operating Cash Flow
$-4.2M
↓ 53.37%
Investing Cash Flow
$-85.4M
↓ 2370.78%
Financing Cash Flow
$100.2M
↑ 3529.57%
FY19Y/Y Change
Operating Cash Flow
$-15.8M
↑ 279.07%
Investing Cash Flow
$-2.1M
↓ 97.49%
Financing Cash Flow
$14.4M
↓ 85.65%
FY20Y/Y Change
Operating Cash Flow
$-19.9M
↑ 25.67%
Investing Cash Flow
$-156.2M
↑ 7175.17%
Financing Cash Flow
$189.4M
↑ 1217.69%
FY21Y/Y Change
Operating Cash Flow
$-13.8M
↓ 30.65%
Investing Cash Flow
$23.5M
↓ 115.05%
Financing Cash Flow
$-7.6M
↓ 104.04%
FY22Y/Y Change
Operating Cash Flow
$-22.1M
↑ 60.67%
Investing Cash Flow
$44.0M
↑ 87.23%
Financing Cash Flow
$-7.1M
↓ 7.63%
Q2 FY23Q/Q Change
Operating Cash Flow
$3.0M
↓ 173.82%
Investing Cash Flow
$-16.1M
↓ 155.81%
Financing Cash Flow
$3.0M
↓ 154.27%

Atricure Technicals Summary

Sell

Neutral

Buy

Atricure is currently in a neutral trading position according to technical analysis indicators.

Atricure Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Atricure Inc
-5.63%
44.02%
-8.56%
-51.75%
-4.98%
Intuitive Surgical, Inc.
-0.66%
21.03%
62.77%
64.44%
174.14%
Resmed Inc.
-5.35%
21.72%
34.09%
-2.39%
47.02%
Becton, Dickinson And Company
2.44%
3.16%
-7.78%
-11.85%
-16.48%
West Pharmaceutical Services Inc
4.16%
5.31%
-4.63%
-14.52%
121.55%
Alcon Ag
-2.79%
-5.54%
8.67%
7.04%
46.91%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Atricure Inc
34.48
NA
-1.18
-0.74
-0.08
-0.04
NA
9.54
Intuitive Surgical, Inc.
84.05
84.05
3.87
6.86
0.16
0.08
NA
43.75
Resmed Inc.
30.29
30.29
1.74
9.35
0.24
0.13
0.01
35.39
Becton, Dickinson And Company
38.78
38.78
1.04
14.37
0.06
0.03
0.02
89.47
West Pharmaceutical Services Inc
48.53
48.53
6.12
6.66
0.18
0.1
0.0
37.96
Alcon Ag
36.28
36.28
3.1
3.03
0.06
0.03
0.0
43.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Atricure Inc
Buy
$1.6B
-4.98%
34.48
-8.7%
Intuitive Surgical, Inc.
Buy
$185.9B
174.14%
84.05
28.51%
Resmed Inc.
Buy
$33.6B
47.02%
30.29
23.15%
Becton, Dickinson And Company
Buy
$65.8B
-16.48%
38.78
7.13%
West Pharmaceutical Services Inc
Buy
$23.7B
121.55%
48.53
17.37%
Alcon Ag
Buy
$42.1B
46.91%
36.28
11.89%

About Atricure

atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 100,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.
Organization
Atricure
Employees
1200
CEO
Mr. Michael H. Carrel
Industry
Health Technology

Management People of Atricure

NameTitle
Mr. Michael H. Carrel
CEO, President & Director
Ms. Angela L. Wirick CPA
Chief Financial Officer
Mr. Douglas J. Seith
Chief Operating Officer
Mr. Salvatore Privitera J.D.
Chief Technical Officer
Mr. Karl S. Dahlquist CCEP, J.D.
Chief Legal Officer
Dr. Vinayak Doraiswamy Ph.D.
Chief Scientific Officer
Valerie Storch-Willhaus
Vice President of Corporate Marketing & Communications
Mr. Justin J. Noznesky
Chief Marketing & Strategy Officer
Ms. Deborah Yount
Chief Human Resources Officer

Important FAQs about investing in Atricure from India :

What is Atricure share price today?

Atricure share price today stands at $33.47, Open: $32.12 ; Previous Close: $32.03 ; High: $34.25 ; Low: $32.49 ; 52 Week High: $39.05 ; 52 Week Low: $18.94. The stock opens at $32.12, after a previous close of $32.03. The stock reached a daily high of $34.25 and a low of $32.49, with a 52-week high of $39.05 and a 52-week low of $18.94.

Can Indians buy Atricure shares?

Yes, Indians can invest in the Atricure (ATRC) from India.

With INDmoney, you can buy Atricure at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Atricure at zero transaction cost.

How can I buy Atricure shares from India?

It is very easy to buy Atricure from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Atricure be purchased?

Yes, you can buy fractional shares of Atricure with INDmoney app.

What are the documents required to start investing in Atricure stocks?

To start investing in Atricure, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Atricure

Today’s highest price of Atricure (ATRC) is $34.25.

Today’s lowest price of Atricure (ATRC) is $32.49.

What is today's market capitalisation of Atricure

Today's market capitalisation of Atricure ATRC is 1.6B

What is the 52 Week High and Low Range of Atricure

  • 52 Week High

    $39.05

  • 52 Week Low

    $18.94

What are the historical returns of Atricure?

  • 1 Month Returns

    -5.63%

  • 3 Months Returns

    44.02%

  • 1 Year Returns

    -8.56%

  • 5 Years Returns

    -4.98%

Who is the Chief Executive Officer (CEO) of Atricure

Mr. Michael H. Carrel is the current Chief Executive Officer (CEO) of Atricure.